Deloitte & Touche's FDA CDER Business Intelligence BPA Call Closed Out at $38.9 Million
A blanket purchase agreement call between Deloitte & Touche LLP and the FDA's Center for Drug Evaluation and Research reached $38,889,552.06 in total obligations before its period of performance closed in June 2024.
FMG Newsroom